Akums Drugs and Pharmaceutical (AKUMS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Akums Drugs and Pharmaceutical (AKUMS) has a cash flow conversion efficiency ratio of 0.364x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.52 Billion ≈ $124.61 Million USD) by net assets (Rs31.68 Billion ≈ $342.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Akums Drugs and Pharmaceutical (AKUMS) market capitalisation for the company's overall valuation and market capitalisation.
Akums Drugs and Pharmaceutical - Cash Flow Conversion Efficiency Trend (2022–2026)
This chart illustrates how Akums Drugs and Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Akums Drugs and Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Akums Drugs and Pharmaceutical ranked by their cash flow conversion efficiency. Explore Akums Drugs and Pharmaceutical earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MeHow Innovative Ltd. A
SHE:301363
|
N/A |
|
Kinco Automation (Shanghai) Co. Ltd. A
SHG:688160
|
N/A |
|
Goosehead Insurance Inc
NASDAQ:GSHD
|
-0.084x |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
0.000x |
|
Taiwan FamilyMart Co Ltd
TWO:5903
|
0.445x |
|
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
|
0.031x |
|
Bega Cheese Ltd
AU:BGA
|
0.170x |
|
Limin Chemical Co Ltd
SHE:002734
|
0.028x |
Annual Cash Flow Conversion Efficiency for Akums Drugs and Pharmaceutical (2022–2026)
The table below shows the annual cash flow conversion efficiency of Akums Drugs and Pharmaceutical from 2022 to 2026. View Akums Drugs and Pharmaceutical (AKUMS) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs33.31 Billion ≈ $360.25 Million |
Rs12.11 Billion ≈ $130.94 Million |
0.363x | +139.36% |
| 2025-03-31 | Rs30.64 Billion ≈ $331.32 Million |
Rs4.65 Billion ≈ $50.31 Million |
0.152x | -78.04% |
| 2024-03-31 | Rs7.20 Billion ≈ $77.92 Million |
Rs4.98 Billion ≈ $53.88 Million |
0.692x | +183.22% |
| 2023-03-31 | Rs7.23 Billion ≈ $78.23 Million |
Rs1.77 Billion ≈ $19.10 Million |
0.244x | +379.22% |
| 2022-03-31 | Rs6.25 Billion ≈ $67.61 Million |
Rs318.54 Million ≈ $3.44 Million |
0.051x | -- |
About Akums Drugs and Pharmaceutical
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offe… Read more